UNITED STATES ORTHOGNATHIC CRANIOMAXILLOFACIAL (CMF) DEVICES MARKET FORECAST 2025-2032

The overall growth in the non-durable medical products sector, which includes surgical devices like CMF products, is a strong indicator of the market’s potential. According to the Centers for Medicare & Medicaid Services, spending on non-durable medical products rose by 7.3% to $124.1 billion in 2023. This uptick reflects broader investments in medical devices and innovations, signaling a favorable economic environment for CMF device manufacturers.

As reported by the American Dental Association, in 2023, the national dental care expenditures in the United States totaled $174 billion, marking a 2.5% increase from 2022. Private health insurance constituted the largest share of these expenditures, followed by out-of-pocket spending. This upward trend underscores the growing emphasis on oral and maxillofacial healthcare, significantly influencing the orthognathic CMF devices market. 

The increased financial commitment, supported by enhanced insurance coverage and rising patient willingness to invest in corrective and aesthetic procedures, is expected to drive the adoption of advanced cranio-maxillofacial devices, further strengthening the market’s growth trajectory.

The United States Coding & Marking Market: 8.48% CAGR (2025-2032)

Need a custom report or have specific data requirements? Let us know!

The United States CMF devices industry is poised for further growth as manufacturers focus on developing more efficient and patient-specific solutions. For example, the adoption of bioresorbable and lightweight materials is expected to enhance patient comfort and reduce complications, making CMF devices more widely accepted. Additionally, partnerships between device manufacturers and healthcare providers are likely to streamline the integration of cutting-edge technologies into surgical practices, driving better outcomes.

The United States orthognathic craniomaxillofacial devices market is segmented into product type, material, and end-user. The material category is further segmented into metal, bioabsorbable material, ceramic, and other materials. 

Bioabsorbable materials are frequently used in plates, screws, and fixation devices to stabilize fractured or reconstructed areas. Unlike traditional metallic implants, which often require secondary surgical procedures for removal, bioabsorbable materials naturally degrade within the body, eliminating the need for additional interventions. 

This reduces patient discomfort, minimizes the risk of surgical complications, and decreases overall recovery time. The use of bioabsorbable materials also addresses concerns related to long-term implant presence, such as infection, inflammation, and interference with diagnostic imaging. As these materials break down into biocompatible byproducts, they are safely absorbed or excreted by the body, ensuring a seamless integration with biological processes.

Furthermore, advances in polymer technology have allowed manufacturers to tailor the mechanical properties and degradation rates of bioabsorbable materials, ensuring they meet the specific requirements of different surgical applications. This adaptability makes them highly versatile in treating a wide range of conditions, from trauma-related injuries to congenital deformities requiring corrective jaw surgeries.

Some of the key players operating in the United States orthognathic craniomaxillofacial devices market include KLS Martin, Acumed LLC (OsteoMed), and DePuSynthes (Johnson & Johnson Inc), etc. 

Acumed LLC is a privately held medical device manufacturer. The company specializes in the development and production of surgical devices and orthopedic implants. Acumed designs implant products used in the reconstruction and repair of trauma-related injuries. 

The company’s offerings include screws, plates, and other devices intended for use in various parts of the body, such as the feet, ankles, fingers, arms, and shoulders. The company was founded in 1988 and is headquartered in Oregon, the United States.